RenaMed Biologics' Series B Round

RenaMed Biologics raised a round of funding on January 01, 2001.

RenaMed Biologics, a University of Michigan spin-out from the late 90s, is a clinical stage cellular therapy company dedicated to the design, development, and commercialization of human cell replaceme…

Articles about RenaMed Biologics' Series B Round: